The results of the Immune Tolerance Network's (ITN) «Persistence of Oral Tolerance to Peanut» (LEAP - ON), discussed on March 4, 2016 at the American Academy of Allergy, Asthma & Immunology Annual Meeting and published in the New England Journal of Medicine, demonstrate that peanut allergy prevention achieved from
early peanut consumption in at - risk infants persists after a one - year period of avoiding peanut.
In addition, the LEAP study design excluded 9.1 % of the infants who were screened (76 of 834) because large wheals (greater than 4 mm in diameter) developed after the skin - prick test21 that were probably associated with peanut allergy; the safety and effectiveness of
early peanut consumption in that population remain unknown.
The results of the Immune Tolerance Network's (ITN) «Learning
Early About
Peanut» (LEAP), discussed on February 23, 2015 at the American Academy of Allergy, Asthma & Immunology Annual Meeting and published in the New England Journal of Medicine, demonstrate that consumption of a peanut - containing snack by infants who are at high - risk for developing peanut allergy prevents the subsequent development of al
Peanut» (LEAP), discussed on February 23, 2015 at the American Academy of Allergy, Asthma & Immunology Annual Meeting and published in the New England Journal of Medicine, demonstrate that
consumption of a
peanut - containing snack by infants who are at high - risk for developing peanut allergy prevents the subsequent development of al
peanut - containing snack by infants who are at high - risk for developing
peanut allergy prevents the subsequent development of al
peanut allergy prevents the subsequent development of allergy.